Zhenwei Peng

Zhenwei Peng

Sun Yat Sen University - / China
Others
AD Scientific Index ID: 718650
太阳森大学
person_outline Zhenwei Peng's MOST POPULAR ARTICLES
1-) Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trialZW Peng, YJ Zhang, MS Chen, L Xu, HH Liang, XJ Lin, RP Guo, ...Journal of clinical oncology 31 (4), 426-432, 20135092013
2-) Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative studyZW Peng, XJ Lin, YJ Zhang, HH Liang, RP Guo, M Shi, MS ChenRadiology 262 (3), 1022-1033, 20122562012
3-) Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversalN Ikenaga, ZW Peng, KA Vaid, SB Liu, S Yoshida, DY Sverdlov, ...Gut 66 (9), 1697-1708, 20172332017
4-) Lenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma: a phase III, randomized clinical trial (LAUNCH)Z Peng, W Fan, B Zhu, G Wang, J Sun, C Xiao, F Huang, R Tang, ...Journal of Clinical Oncology 41 (1), 117-127, 20232672023
5-) Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trialZW Peng, YJ Zhang, HH Liang, XJ Lin, RP Guo, MS ChenRadiology 262 (2), 689-700, 20122602012